Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the american association for the study of liver diseases, american society of transplantation and the north american society for pediatric gastroenterology, hepatolo

Combined hepatocellular‐cholangiocarcinoma: A population‐level analysis of an uncommon primary liver tumor

Mattia Garancini, Paolo Goffredo, Fabio Pagni, Fabrizio Romano, Sanziana Roman, Julie Ann Sosa, Vittorio Giardini – 29 April 2014 – Combined hepatocellular‐cholangiocarcinoma (cHCC‐CC) is a rare primary liver cancer. Our aims were to analyze the demographic, clinical, and pathological characteristics of cHCC‐CC at a population level and to investigate the effects of these features as well as different management strategies on the prognosis. The Surveillance, Epidemiology, and End Results (SEER) database was analyzed for 1988‐2009.

Comparative effectiveness of liver transplant strategies for end‐stage liver disease patients on renal replacement therapy

Yaojen Chang, Lorenzo Gallon, Colleen Jay, Kirti Shetty, Bing Ho, Josh Levitsky, Talia Baker, Daniela Ladner, John Friedewald, Michael Abecassis, Gordon Hazen, Anton I. Skaro – 29 April 2014 – There are complex risk‐benefit tradeoffs with different transplantation strategies for end‐stage liver disease patients on renal support.

Subscribe to